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Dear Editor, 
A recent retrospective study on Helicobacter pylori (H. pylori) prevalence was 
carried out from 2005 to 2017 on all children who underwent 
esophagogastroduodenoscopy (EGDS) due to symptoms suggestive of peptic 
diseases e.g. dyspepsia, or symptoms of gastrointestinal bleeding in Hong Kong 
region: 602 patients were included; 317 were girls and 285 were boys, mean age 
13.4 years. From the results of the study, the authors hypothesized that the 
reduction in prevalence of H. pylori infection among adults and the decrease in the 
practice of sharing chopsticks during meals have led to a decrease in transmission of 
the bacteria among family members in Hong Kong. Furthermore, the failure of 
eradication with first line treatment was higher, possibly due to the increase in 
antibiotics usage and resistance. 
Some aspects of this interesting study deserve a comment. 
H. pylori is a slow-growing, micro-aerophilic, Gram-negative bacterium, 
usually acquired during childhood, whose natural habitat is the luminal surface of the 
gastric epithelium.  
At least 50% of the world’s human population carries the microorganism, with 
a prevalence much higher in developing countries than in developed countries [1].  
Tang et al. [1] found an overall infection rate of H. pylori infection of 12.8% 
(95% CI, 10.1–15.5%), which was lower when compared to the figure of 25.6% from 
their previous review in 2005 [2].  
This finding is not surprising since H. pylori infection is acquired in the 
preschool period and the risk declines sharply after 5 years of age. The higher 
prevalence in older age groups is thought to reflect a cohort-effect related to poorer 
living conditions in the past during childhood. 
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More surprising is the fact that only 10.3% of patients with gastritis and 39.5% 
of those with peptic ulcer disease had H. pylori infection. 
The authors of the study [2] searched for H. pylori infection performing 
biopsies from the antrum. This is a correct approach if the patient is not currently 
treated with a proton pump inhibitor (PPI) drug and if patient does not undergo to 
EGDS due to gastrointestinal bleeding, in which cases false negative results may 
occur [3]. No data about the use of PPI by the children is given and a percentage of 
the patients underwent to EGDS due to gastrointestinal bleeding. Given these 
circumstances, a second test should have been done in case of H. pylori negativity 
to confirm these results. 
H. pylori infection is accepted as the most important cause of gastritis and 
peptic ulcer in humans. Both H. pylori infection and non-steroidal anti-inflammatory 
drug (NSAID) use are independent risk factors for the development of peptic ulcer 
and associated bleeding. Data regarding the NSAID use from the study population 
would enrich the results. 
A second interesting results was that the eradication rate with 1-week triple 
therapy (clarithromycin plus amoxicillin plus omeprazole) was only successful in 
70.7%. This is not surprising since, at least in the West, the 1-week triple therapy 
has been abandoned due to the insufficient eradication rate [4]. Regarding the 
population in study the authors did not report data about a possible previous H. pylori 
treatment: hence, it is possible that someone could underwent to eradication 
treatment and this would influence the outcome of the study regarding both the H. 
pylori prevalence (in patients in which the previous therapy has been successful) and 
the eradication rate (in patients in which the previous therapy has not been 
successful). 
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